These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis. Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078 [TBL] [Abstract][Full Text] [Related]
46. Monoclonal anti-idiotypic antibodies that mimic the epitope on gp120 defined by anti-HIV-1 monoclonal antibody 0.5 beta. Sperlagh M; Stefano K; Gonzalez-Scarano F; Liang S; Hoxie J; Maruyama H; Prewett M; Matsushita S; Herlyn D AIDS; 1993 Dec; 7(12):1553-9. PubMed ID: 7506914 [TBL] [Abstract][Full Text] [Related]
47. Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response. Ma J; Zhou L; Wang D Jpn J Cancer Res; 2002 Jan; 93(1):78-84. PubMed ID: 11802811 [TBL] [Abstract][Full Text] [Related]
48. Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes. Bhattacharya-Chatterjee M; Pride MW; Seon BK; Kohler H J Immunol; 1987 Aug; 139(4):1354-60. PubMed ID: 3497200 [TBL] [Abstract][Full Text] [Related]
49. Idiotype vaccine against Hodgkin's lymphoma: generation and characterization of an anti-idiotypic monoclonal antibody against the Hodgkin-associated (anti-CD 30) monoclonal antibody HRS-3. Pohl C; Sieber M; Diehl V; Pfreundschuh M Anticancer Res; 1991; 11(3):1115-24. PubMed ID: 1653553 [TBL] [Abstract][Full Text] [Related]
50. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice. Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392 [TBL] [Abstract][Full Text] [Related]
51. A monoclonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen. Gaida FJ; Fenger U; Wagener C; Neumaier M Int J Cancer; 1992 May; 51(3):459-65. PubMed ID: 1592535 [TBL] [Abstract][Full Text] [Related]
52. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy? Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H Cancer Immunol Immunother; 1994 Mar; 38(3):149-59. PubMed ID: 8124683 [TBL] [Abstract][Full Text] [Related]
53. Immune events associated with protection in C57BL/6 mice immunized with anti-idiotypic antibodies mimicking protective antigens shared between gamma-irradiated cercariae vaccine and human resistance model of Schistosoma haematobium. Abdeen SH Egypt J Immunol; 2010; 17(2):105-19. PubMed ID: 23082491 [TBL] [Abstract][Full Text] [Related]
54. Idiotype vaccine for tumor by anti-idiotypic antibody prepared against anti-(bacillus Calmette Guèrin)BCG monoclonal antibody. Sasaki J; Tamagake T; Narita S; Ahsan CR Cancer Immunol Immunother; 1990; 31(5):273-7. PubMed ID: 2198089 [TBL] [Abstract][Full Text] [Related]
55. Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigen. Kim KM; Shin EY; Moon JH; Heo TH; Lee JY; Chung Y; Lee YJ; Cho HM; Shin SU; Kang CY Int J Cancer; 2002 Dec; 102(4):428-34. PubMed ID: 12402315 [TBL] [Abstract][Full Text] [Related]
56. The analysis of internal image-bearing anti-idiotypic monoclonal antibody in relation to carcinoembryonic antigen. Tsujisaki M; Hinoda Y; Tokuchi S; Hanzawa Y; Arimura Y; Masuya J; Kitagawa H; Okochi E; Shimamura T; Hamuro J J Immunol; 1993 Jan; 150(2):508-16. PubMed ID: 8419483 [TBL] [Abstract][Full Text] [Related]
57. Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours. Durrant LG; Doran M; Austin EB; Robins RA Int J Cancer; 1995 Mar; 61(1):62-6. PubMed ID: 7705934 [TBL] [Abstract][Full Text] [Related]
58. Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2. Sen G; Chakraborty M; Foon KA; Reisfeld RA; Bhattacharya-Chatterjee MB J Immunother; 1998 Jan; 21(1):75-83. PubMed ID: 9456440 [TBL] [Abstract][Full Text] [Related]
59. Induction of the immune response to Legionella pneumophila cytolysin by monoclonal anti-idiotypic antibodies. Spitsin SV; Drobyshevskaya EI; Barkhatova OI; Belyi YF; Tartakovsky IS; Nesterenko VG J Immunol; 1991 Sep; 147(6):2001-5. PubMed ID: 1890309 [TBL] [Abstract][Full Text] [Related]
60. Recognition of angiotensin II: antibodies at different levels of an idiotypic network are superimposable. Garcia KC; Desiderio SV; Ronco PM; Verroust PJ; Amzel LM Science; 1992 Jul; 257(5069):528-31. PubMed ID: 1636087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]